Corrigendum: Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell Lung Cancer

Yuzhong Chen; Shaodi Wen; Jingwei Xia; Xiaoyue Du; Yuan Wu; Banzhou Pan; Wei Zhu; Bo Shen

doi:10.3389/fimmu.2021.713268

Corrigendum: Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell Lung Cancer

Front Immunol. 2021 Jun 7:12:713268. doi: 10.3389/fimmu.2021.713268. eCollection 2021.

Authors

Yuzhong Chen¹, Shaodi Wen¹, Jingwei Xia¹, Xiaoyue Du¹, Yuan Wu¹, Banzhou Pan¹, Wei Zhu², Bo Shen¹

Affiliations

¹ The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.
² Key Hematological of Medical Science and Hematological Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, China.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2021.672271.].

Keywords: PD-1 inhibitor; carcinoembryonic antigen; combination therapy; neuron-specific enolase; neutrophil-to-lymphocyte ratio; non-small cell lung cancer.

Publication types

Published Erratum